Sickle Cell Disease Treatment in Low-Resource Settings: Bridging the Gap

Sickle Cell Disease (SCD) is a genetic blood disorder caused by the inheritance of abnormal hemoglobin genes. This condition primarily affects individuals of African, Mediterranean, Middle Eastern, and Indian ancestry, and it presents significant challenges for both patients and healthcare providers. Characterized by the distortion of red blood cells into a sickle shape, SCD leads to a range of complications, including anemia, pain crises, organ damage, and increased vulnerability to infections. For decades, managing this disease primarily involved symptomatic treatment and supportive care. However, recent advances in medical science have significantly improved the outlook for individuals with SCD, offering new hope through innovative therapies and curative approaches.

For More Info: https://www.transparencyma...